564 related articles for article (PubMed ID: 25619191)
1. Racial disparities in prostate cancer incidence rates by census division in the United States, 1999-2008.
Cook MB; Rosenberg PS; McCarty FA; Wu M; King J; Eheman C; Anderson WF
Prostate; 2015 May; 75(7):758-63. PubMed ID: 25619191
[TBL] [Abstract][Full Text] [Related]
2. Trends in the Incidence of Fatal Prostate Cancer in the United States by Race.
Kelly SP; Rosenberg PS; Anderson WF; Andreotti G; Younes N; Cleary SD; Cook MB
Eur Urol; 2017 Feb; 71(2):195-201. PubMed ID: 27476048
[TBL] [Abstract][Full Text] [Related]
3. Geographic Distribution of Racial Differences in Prostate Cancer Mortality.
Fletcher SA; Marchese M; Cole AP; Mahal BA; Friedlander DF; Krimphove M; Kilbridge KL; Lipsitz SR; Nguyen PL; Choueiri TK; Kibel AS; Trinh QD
JAMA Netw Open; 2020 Mar; 3(3):e201839. PubMed ID: 32232449
[TBL] [Abstract][Full Text] [Related]
4. Ultraviolet index and racial differences in prostate cancer incidence and mortality.
Taksler GB; Cutler DM; Giovannucci E; Smith MR; Keating NL
Cancer; 2013 Sep; 119(17):3195-203. PubMed ID: 23744754
[TBL] [Abstract][Full Text] [Related]
5. Racial and Ethnic Disparities in Prostate Cancer Outcomes in the Veterans Affairs Health Care System.
Yamoah K; Lee KM; Awasthi S; Alba PR; Perez C; Anglin-Foote TR; Robison B; Gao A; DuVall SL; Katsoulakis E; Wong YN; Markt SC; Rose BS; Burri R; Wang C; Aboiralor O; Fink AK; Nickols NG; Lynch JA; Garraway IP
JAMA Netw Open; 2022 Jan; 5(1):e2144027. PubMed ID: 35040965
[TBL] [Abstract][Full Text] [Related]
6. Regional variations in esophageal cancer rates by census region in the United States, 1999-2008.
Drahos J; Wu M; Anderson WF; Trivers KF; King J; Rosenberg PS; Eheman C; Cook MB
PLoS One; 2013; 8(7):e67913. PubMed ID: 23861830
[TBL] [Abstract][Full Text] [Related]
7. Prostate Cancer Incidence and PSA Testing Patterns in Relation to USPSTF Screening Recommendations.
Jemal A; Fedewa SA; Ma J; Siegel R; Lin CC; Brawley O; Ward EM
JAMA; 2015 Nov; 314(19):2054-61. PubMed ID: 26575061
[TBL] [Abstract][Full Text] [Related]
8. Is prostate cancer different in black men? Answers from 3 natural history models.
Tsodikov A; Gulati R; de Carvalho TM; Heijnsdijk EAM; Hunter-Merrill RA; Mariotto AB; de Koning HJ; Etzioni R
Cancer; 2017 Jun; 123(12):2312-2319. PubMed ID: 28436011
[TBL] [Abstract][Full Text] [Related]
9. Racial Disparities in the Presentation, Early Definitive Surgical Treatment, and Mortality Among Men Diagnosed with Poorly Differentiated/Undifferentiated Non-metastatic Prostate Cancer in the USA.
Lediju O; Ikuemonisan J; Salami SS; Adejoro O
J Racial Ethn Health Disparities; 2019 Apr; 6(2):401-408. PubMed ID: 30506310
[TBL] [Abstract][Full Text] [Related]
10. Cancer surveillance series: interpreting trends in prostate cancer--part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates.
Hankey BF; Feuer EJ; Clegg LX; Hayes RB; Legler JM; Prorok PC; Ries LA; Merrill RM; Kaplan RS
J Natl Cancer Inst; 1999 Jun; 91(12):1017-24. PubMed ID: 10379964
[TBL] [Abstract][Full Text] [Related]
11. Prostate-specific antigen testing in black and white men: an analysis of medicare claims from 1991-1998.
Etzioni R; Berry KM; Legler JM; Shaw P
Urology; 2002 Feb; 59(2):251-5. PubMed ID: 11834397
[TBL] [Abstract][Full Text] [Related]
12. Prevalence-corrected prostate cancer incidence rates and trends.
Merrill RM; Morris MK
Am J Epidemiol; 2002 Jan; 155(2):148-52. PubMed ID: 11790678
[TBL] [Abstract][Full Text] [Related]
13. Disparities in treatment patterns and mortality in prostate cancer: Interaction between Black race and end-stage kidney disease.
Sarabu N; Dong W; Koroukian SM
Cancer Med; 2024 May; 13(10):e7027. PubMed ID: 38770622
[TBL] [Abstract][Full Text] [Related]
14. Racial Disparities and Trends in Pancreatic Cancer Incidence and Mortality in the United States.
Tavakkoli A; Singal AG; Waljee AK; Elmunzer BJ; Pruitt SL; McKey T; Rubenstein JH; Scheiman JM; Murphy CC
Clin Gastroenterol Hepatol; 2020 Jan; 18(1):171-178.e10. PubMed ID: 31202981
[TBL] [Abstract][Full Text] [Related]
15. Evidence supports a faster growth rate and/or earlier transformation to clinically significant prostate cancer in black than in white American men, and influences racial progression and mortality disparity.
Powell IJ; Bock CH; Ruterbusch JJ; Sakr W
J Urol; 2010 May; 183(5):1792-6. PubMed ID: 20299055
[TBL] [Abstract][Full Text] [Related]
16. Trends in prostate cancer mortality among black men and white men in the United States.
Chu KC; Tarone RE; Freeman HP
Cancer; 2003 Mar; 97(6):1507-16. PubMed ID: 12627516
[TBL] [Abstract][Full Text] [Related]
17. Racial variation in prostate cancer incidence and in hormonal system markers among male health professionals.
Platz EA; Rimm EB; Willett WC; Kantoff PW; Giovannucci E
J Natl Cancer Inst; 2000 Dec; 92(24):2009-17. PubMed ID: 11121463
[TBL] [Abstract][Full Text] [Related]
18. Past, Current, and Future Incidence Rates and Burden of Metastatic Prostate Cancer in the United States.
Kelly SP; Anderson WF; Rosenberg PS; Cook MB
Eur Urol Focus; 2018 Jan; 4(1):121-127. PubMed ID: 29162421
[TBL] [Abstract][Full Text] [Related]
19. Income inequality and treatment of African American men with high-risk prostate cancer.
Ziehr DR; Mahal BA; Aizer AA; Hyatt AS; Beard CJ; D Amico AV; Choueiri TK; Elfiky A; Lathan CS; Martin NE; Sweeney CJ; Trinh QD; Nguyen PL
Urol Oncol; 2015 Jan; 33(1):18.e7-18.e13. PubMed ID: 25306287
[TBL] [Abstract][Full Text] [Related]
20. Prostate cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study.
Steele CB; Li J; Huang B; Weir HK
Cancer; 2017 Dec; 123 Suppl 24(Suppl 24):5160-5177. PubMed ID: 29205313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
